Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed an ...
Agreement provides additional funding tool of up to $25 million over a period of up to 36 months - Underpins the Company’s ambitions to expand its commercialisation activities and advance its ...
SPARK NS will release a Call for Proposals for the 2027 Cohort of the program in March 2026. For the 2027 Cohort, SPARK NS will accept applications from principal investigators in the US, Canada, UK, ...
Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class, smart-safety syringe products to the healthcare industry. The Company’s product ...
AIM ImmunoTech Inc. (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of its lead product, Ampligen® (rintatolimod), for the treatment of late-stage pancreatic ...
Participants may access the live webcast on the Codexis Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing 877-705-2976 (domestic) or ...
Increasing doses of laromestrocel are associated with decreases in soluble (degraded) tyrosine kinase with immunoglobulin and epidermal growth factor homology domains (TIE-2), the cognate receptor for ...
Revenue Growth – Precipio’s revenues increased from $18.5M in 2024 to $24.0M in 2025, an increase of 30% year over year. Q4-2025 revenues were $6.7M, an increase of 23% YoY from $5.4M in Q4-2024.
HANOVER, Md., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Swing into action and support your greater Maryland community. Johns Hopkins Health Plans invites local businesses and community partners to sponsor the ...
The capital will support the continued expansion of Baba's Medicare-covered advocacy services, deepen partnerships with providers and health systems, and advance its long-term mission to make ...
Dr. Ben Reinking is the founder of The Developing Doctor, a platform dedicated to helping high-achieving professionals navigate the mental and emotional challenges that often accompany success. A ...
Genmab A/S (Nasdaq: GMAB) announced today that members of its Executive Committee will participate in fireside chats at the following investor conferences in March 2026: The live and archived webcast ...